Article
A Multicenter, Prospective, Observational Study to Determine the Incidence of Febrile Neutropenia (FN), Persistence and G-CSF Utilization Among Cancer Patients at High Risk for FN Receiving Pegfilgrastim by an On-body Injector (OBI) versus other FN Prophylaxis Strategies: An Interim Analysis
Cancer Research / San Antonio Breast Cancer Symposium
(2021)
Abstract
J. Crawford; R. Rifkin; D. Dale; A. Brookhart; P. Gawade; S. Lewis; T. Lawrence; R. Belani; G. Lyman
Disciplines
Publication Date
February 15, 2021
Citation Information
Reshma Mahtani. "A Multicenter, Prospective, Observational Study to Determine the Incidence of Febrile Neutropenia (FN), Persistence and G-CSF Utilization Among Cancer Patients at High Risk for FN Receiving Pegfilgrastim by an On-body Injector (OBI) versus other FN Prophylaxis Strategies: An Interim Analysis" Cancer Research / San Antonio Breast Cancer Symposium Vol. 81 Iss. 4 Supplement (2021) Available at: http://works.bepress.com/reshma-mahtani/47/